CHRISTIANSON MARK (Business Development Director) sold 7.2% of their position (15.36K shares) of NEUROONE MEDICAL TECHNOLOGIES CORP on the open market
Open‑market sale worth $11.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/1/2026ACC: 0001709738-26-000009
Officer· Business Development Director
Since Feb 2026
-15.62K
Net shares
Net seller
$11.6K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
15.62K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−15.36K
Price / share
$0.74
Trade value
$11.37K
% of position
7.2%
3/30/2026
214.28K→198.92K
Common Stock
Direct
Shares
−253.00
Price / share
$0.78
Trade value
$196.58
% of position
0.1%
3/31/2026
198.92K→198.67K
Total
Net shares
−15.62K
Net value
-$11.57K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/30/2026 | S · Sale | −15.36K | $0.74 | $11.37K | 7.2% | 214.28K | 198.92K |
| Common Stock Direct | 3/31/2026 | F · Tax Withholding | −253.00 | $0.78 | $196.58 | 0.1% | 198.92K | 198.67K |
| Total | −15.62K | -$11.57K | ||||||
Derivative Transactions0
No derivative transactions reported